Login / Signup

Multicenter prospective phase II trial of nivolumab in patients with unresectable or metastatic mucosal melanoma.

Motoo NomuraIsao OzeToshiki MasuishiTomoya YokotaHironaga SatakeShunichiro IwasawaKen KatoMasashi Andoh
Published in: International journal of clinical oncology (2020)
Although this trial met the primary endpoint, the RR was still unsatisfactory. Therefore, further treatment development is required.
Keyphrases
  • squamous cell carcinoma
  • small cell lung cancer
  • clinical trial
  • study protocol
  • tyrosine kinase
  • randomized controlled trial
  • locally advanced
  • radiation therapy
  • combination therapy
  • double blind
  • rectal cancer